Cognitive Effects of Life Kinetik-Adapted Physical Activity Cards

January 12, 2026 updated by: Enes Sucular

The Effect of Physical Activity Cards Adapted With Life Kinetik Exercises on Cognitive Functions and Problem-solving Skills in Middle School Students: a Randomized Controlled Trial

The purpose of this study is to investigate the effects of physical activity cards integrated with Life Kinetik exercises on attention, short-term memory, cognitive flexibility, and problem-solving skills in middle school students. The study specifically aims to determine whether this integrated educational approach leads to greater improvements in cognitive performance compared to traditional physical activity cards.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study evaluated the effects of physical activity cards adapted with Life Kinetik exercises on cognitive functions and problem-solving skills in middle school students. A total of 36 participants aged 11-14 years were assigned to two experimental groups (physical activity cards adapted with Life Kinetik and physical activity card) and one control group in a 12-week intervention designed with a pre-test-post-test experimental model. The PAC-LK group participated in physical activity cards integrated with Life Kinetik exercises, while the physical activity card group followed traditional physical activity cards, each conducted three times per week for one hour, and the control group did not receive any intervention. The integrated program combined physical movement with cognitive tasks to stimulate cognitive processing and executive functions. Outcome measures included attention, short-term memory, cognitive flexibility, and problem-solving performance.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
36

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Menteşe
      • Muğla, Menteşe, Turkey (Türkiye), 48040
        • Muğla Sıtkı Koçman University Faculty of Sports Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Secondary school pupils aged 11 to 14,be enrolled in secondary school,Healthy participants with no chronic illnesses, musculoskeletal injuries, or physical limitations in the last six months.

Exclusion Criteria:

  • To be included in an individualised education programme (IEP), Loss of senses such as hearing or sight, Insufficient Turkish reading comprehension skills.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Life Kinetik Group
Participants in this group took part in an intervention involving physical activity cards adapted with Life Kinetik exercises three times a week for 12 weeks. The training program combined physical and cognitive tasks designed to improve cognitive functions and problem-solving skills.
Behavioral: Life Kinetik Adapted Physical Activity Cards Training
A combination of cognitive and physical exercises aimed at developing cognitive functions and problem-solving skills.
Experimental: Fiziksel Activity Group
Participants in this group took part in an intervention involving physical activity cards three times a week for 12 weeks. The training program combined physical and cognitive tasks designed to assess its effect on cognitive functions and problem-solving skills.
Behavioral: Physical activity cards training
Cards used in physical education classes in Turkish middle schools that include movement skills aimed at improving physical fitness.
No Intervention: Control Group
Participants in the control group continued their normal daily lives without any additional intervention. To provide an environment equivalent to the experimental group's exposure, they participated in structured games unrelated to the goals of Life Kinetik and Physical Activity Cards. These activities included light stretching movements and educational games. They were conducted at the same frequency and duration as the experimental sessions (three times a week for one hour). At the end of the study, participants were fully informed about the nature and purpose of their activities, including the rationale for the placebo-like design, as part of the ethical protocol.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Stroop test TBAG form
Time Frame: 12 week
The Stroop Test TBAG Form, physical activity cards adapted with Life Kinetik and physical activity card intervention programmes were used to evaluate their effects on attention and executive functions. The test was specifically applied to assess executive function components that measure focused and selective attention, resistance to distracting stimuli, and information processing speed. The test includes sections such as the Stroop interference score, test speed factor, total time, total number of errors, and total number of corrections. These sections were evaluated to examine the effect on attention and cognitive control processes.The completion time for each section of the test is recorded in seconds. As the time decreases, the performance shown on the test increases. The Stroop Test TBAG Form was developed as part of the BILNOT Battery, a measurement tool with proven validity and reliability, supported by the TÜBİTAK Basic Sciences Research Group.
12 week
Visual Auditory Number Sequences Test Form B
Time Frame: 12 week
The Visual-Auditory Number Sequences Test Form B (VANST-B) was used to assess short-term attention and memory capacity. The test was administered to examine the impact of the physical activity cards adapted with Life Kinetik and physical activity card intervention programs on short-term attention and memory performance. The test includes auditory stimulation, visual stimulation, verbal expression, written explanation, and test total score sections. These sections were evaluated to examine their effects on short-term attention and memory. Before the test, the participants were informed about the application procedure and given a brief trial. Scoring was based on the longest sequence that the participant could correctly repeat.The lowest score obtained in the test is 0, and the highest score is 36. As the score increases, performance improves. The VANST-B is a valid and reliable measurement tool used to assess attention and memory capacity in children.
12 week
Cognitive Flexibility Scale
Time Frame: 12 week
The Cognitive Flexibility Scale (CFS) was used to assess participants' levels of cognitive flexibility. Total scores obtained from the scale were analyzed to determine the effect of the physical activity cards adapted with Life Kinetik and physical activity card intervention programs on cognitive flexibility. This measurement tool is a 6-item Likert-type scale consisting of 12 items and a single subscale. High scores indicate that individuals have high levels of cognitive flexibility, while low scores indicate that they have low levels of cognitive flexibility.
12 week
Problem solving inventory for elementary school children
Time Frame: 12 week
The Problem Solving Inventory for Children at the Primary School Level was used to assess children's problem-solving skills. The total scores obtained from the inventory were analyzed to examine the effects of physical activity cards adapted with Life Kinetik and physical activity card interventions on problem-solving skills.This measurement tool is a 5-point Likert-type scale consisting of 24 items and a single sub-dimension. High scores indicate that individuals have high problem-solving skills, while low scores indicate that problem-solving skills are low.
12 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Enes Sucular

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 2, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 6, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 20, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 30, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 12, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 13, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 13, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 12, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 230037-77

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD will not be shared to ensure the privacy and confidentiality of participants. Additionally, explicit consent for data sharing was not obtained from participants or their guardians during the study, and the ethical approval did not include provisions for sharing individual data externally.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings